Compounds and methods are provided for the treatment of disease conditions in which modification of cholinergic, especially muscarinic m1, m4, or both m1 and m4, receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
提供了用于治疗疾病症状的化合物和方法,在这些疾病症状中,改变
胆碱能,尤其是肌
磷酸激酶m1、m4或m1和m4双重受体活性对疗效有益。在该方法中,向需要此类治疗的患者施用有效量的化合物。